IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Metagenomi Therapeutics Inc (MGX)

CUSIP: 59102M104 | NYSE | Healthcare · Biotechnology | Micro Cap | 143 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13GThomas Brian C.2,762,1427.3%New 5%+ stakeJun 30, 2026No 13F filer matched
13GThomas Brian C.2,762,142
7.3% of class · Jun 30, 2026

Institutional Holders — Q3 2026

Peapod Lane Capital LLC490,992
0.4% of portfolio›$520.5K
Fortitude Advisory Group L.L.C.37,290
0.0% of portfolio›$39.5K
Dimensional Fund Advisors LP12,797
0.0% of portfolio›$13.6K
Caitong International Asset Management Co., Ltd10
0.0% of portfolio›$11
StyleTurnoverLocationFiled
Peapod Lane Capital LLC
490,992$520.5K0.4%Deep ValueMediumBedford Hills, NY2026-10-22
Fortitude Advisory Group L.L.C.
37,290$39.5K0.0%GrowthMediumGig Harbor, WA2026-10-15
Dimensional Fund Advisors LP
12,797$13.6K0.0%IndexLowAustin, TX2026-11-04
Caitong International Asset Management Co., Ltd
10$110.0%GrowthVery HighHong Kong, South Korea2026-10-29
New 5%+ stake
No 13F filer matched